Luca Fania

Evidence for a ‘window of opportunity’ in hidradenitis suppurativa treated with adalimumab: a retrospective, real‐life multicentre cohort study*

Angelo Valerio Marzano, Giovanni Genovese, Giovanni Casazza et al. · British Journal of Dermatology · 2020 · 172 citations · Full text

Medicine, Dermatology, Pharmacotherapy +13

Calculation of cut‐off values based on the Autoimmune Bullous Skin Disorder Intensity Score ( <scp>ABSIS</scp> ) and Pemphigus Disease Area Index ( <scp>PDAI</scp> ) pemphigus scoring systems for defining moderate, significant and extensive types of pemphigus

C. Boulard, S. Duvert Lehembre, C. Picard‐Dahan et al. · British Journal of Dermatology · 2016 · 92 citations · Full text

Medicine, Dermatology, Autoimmunity +16

Effectiveness of Secukinumab in the treatment of moderate–severe hidradenitis suppurativa: results from an Italian multicentric retrospective study in a real‐life setting

Simone Ribero, Alice Ramondetta, Gabriella Fabbrocini et al. · Journal of the European Academy of Dermatology and Venereology · 2021 · 51 citations · Full text

Medicine, Dermatology, Pharmacotherapy +4

IgE recognition of bullous pemphigoid (BP)180 and BP230 in BP patients and elderly individuals with pruritic dermatoses

Luca Fania, Giacomo Caldarola, Ralf Müller et al. · Clinical Immunology · 2012 · 46 citations

Medicine, Dermatology, Immunology +12

Sex‐ and gender‐associated clinical and psychosocial characteristics of patients with psoriasis

Monica Napolitano, Simona Mastroeni, Luca Fania et al. · Clinical and Experimental Dermatology · 2020 · 45 citations

Social Sciences, Dermatology, Psychology +16